Olmesartan Medoxomil And Amlodipine Besylate And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 70436-014
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil And Amlodipine Besylate And Hydrochlorothiazide (NDC 70436-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-1 (Combo Figure 1)
Figure-2 (Combo Figure 2)
70436-014-04 (Fpl Label 20 5 12p5mg 30tabs V1.1.jpg)
This text provides information about a medication labeled as "Olmesartan Medoxom, Amlodipine, and Hydrochlorothiazide Tablets" with a strength of 20 mg/5 mg/12.5mg. The medication comes in a pack of 30 tablets and includes precautions against children accessing the drug. Additionally, it mentions a coating-free area for LOT, EXP, and serialization data.*
Hctz (Hctz Formula)
70436-015-04 (Image 01)
70436-016-04 (Image 02)
70436-017-04 (Image 03)
This text appears to be a partial description of a medication containing Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide. The medication is in tablet form with a specified dosage of 40mg/10mg/12.5mg. Additionally, there is mention of a coating-free area for a product referred to as SLATERUN, along with lot, expiration (EXP), and serialization data. The text provides information about the composition and structure of the mentioned medication.*
70436-018-04 (Image 04)
Olmesartan-medoxomil (Olmesartan Medoxomil Formula)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.